![](/img/cover-not-exists.png)
Germline variant in SLCO2B1 and response to abiraterone acetate plus prednisone (AA) in new onset metastatic castration-resistant prostate cancer (mCRPC)
Hahn, Andrew W, Gill, David M, Poole, Austin, Nussenzveig, Roberto H, Wilson, Sara, Farnham, James M, Stephenson, Robert A, Cannon-Albright, Lisa A., Maughan, Benjamin L, Agarwal, NeerajLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-18-0739
Date:
December, 2018
File:
PDF, 1.11 MB
english, 2018